GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 907 filers reported holding GLAXOSMITHKLINE PLC in Q4 2021. The put-call ratio across all filers is 0.21 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $9,388,000 | -0.2% | 215,668 | -0.1% | 0.22% | +12.8% |
| Q1 2022 | $9,407,000 | -34.2% | 215,958 | -33.4% | 0.20% | -33.7% |
| Q4 2021 | $14,297,000 | +16.1% | 324,206 | +0.6% | 0.29% | +11.4% |
| Q3 2021 | $12,316,000 | -3.4% | 322,329 | +0.7% | 0.26% | -4.7% |
| Q2 2021 | $12,748,000 | +9.5% | 320,133 | -1.8% | 0.28% | +2.2% |
| Q1 2021 | $11,641,000 | -1.4% | 326,166 | +1.7% | 0.27% | -8.4% |
| Q4 2020 | $11,801,000 | -2.7% | 320,677 | -0.5% | 0.30% | -16.6% |
| Q3 2020 | $12,125,000 | -7.3% | 322,134 | +0.5% | 0.36% | -15.1% |
| Q2 2020 | $13,076,000 | +12.4% | 320,567 | +4.4% | 0.42% | -19.0% |
| Q1 2020 | $11,637,000 | -20.8% | 307,116 | -1.8% | 0.52% | -1.5% |
| Q4 2019 | $14,700,000 | +9.9% | 312,838 | -0.1% | 0.52% | -0.2% |
| Q3 2019 | $13,371,000 | +8.4% | 313,287 | +1.6% | 0.52% | +4.8% |
| Q2 2019 | $12,338,000 | -2.7% | 308,305 | +1.6% | 0.50% | -7.1% |
| Q1 2019 | $12,678,000 | +14.0% | 303,377 | +4.2% | 0.54% | -1.5% |
| Q4 2018 | $11,120,000 | +13.2% | 291,027 | +19.0% | 0.55% | +27.2% |
| Q3 2018 | $9,822,000 | -2.0% | 244,504 | -1.7% | 0.43% | -7.1% |
| Q2 2018 | $10,025,000 | +5.3% | 248,694 | +2.0% | 0.46% | +2.2% |
| Q1 2018 | $9,524,000 | +34.9% | 243,769 | +22.4% | 0.45% | +40.2% |
| Q4 2017 | $7,061,000 | -3.1% | 199,083 | +10.9% | 0.32% | -9.0% |
| Q3 2017 | $7,288,000 | -5.7% | 179,511 | +0.2% | 0.36% | -7.6% |
| Q2 2017 | $7,727,000 | +2.0% | 179,199 | -0.3% | 0.38% | -0.8% |
| Q1 2017 | $7,577,000 | +13.0% | 179,712 | +3.2% | 0.39% | +8.4% |
| Q4 2016 | $6,704,000 | -12.8% | 174,088 | -1.8% | 0.36% | -22.2% |
| Q2 2016 | $7,686,000 | +10.4% | 177,331 | +3.3% | 0.46% | +6.2% |
| Q1 2016 | $6,963,000 | -1.8% | 171,712 | -2.3% | 0.43% | -5.5% |
| Q4 2015 | $7,091,000 | +0.3% | 175,732 | -4.4% | 0.46% | -6.0% |
| Q3 2015 | $7,071,000 | -9.3% | 183,907 | -1.7% | 0.49% | -2.0% |
| Q2 2015 | $7,794,000 | -1.7% | 187,130 | +9.0% | 0.50% | +0.6% |
| Q1 2015 | $7,925,000 | +6.6% | 171,714 | -1.2% | 0.49% | +4.7% |
| Q4 2014 | $7,431,000 | -5.9% | 173,858 | +1.3% | 0.47% | -15.0% |
| Q3 2014 | $7,894,000 | -12.8% | 171,711 | +1.4% | 0.55% | -12.1% |
| Q2 2014 | $9,052,000 | -14.8% | 169,267 | -14.9% | 0.63% | -17.6% |
| Q1 2014 | $10,623,000 | -5.4% | 198,823 | -5.5% | 0.76% | -9.1% |
| Q4 2013 | $11,228,000 | +11.3% | 210,311 | +4.6% | 0.84% | +1.1% |
| Q3 2013 | $10,090,000 | -3.1% | 201,112 | -3.5% | 0.83% | -3.6% |
| Q2 2013 | $10,409,000 | – | 208,299 | – | 0.86% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
| Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
| KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
| Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
| Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
| EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
| Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
| Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
| CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
| CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |